文献速递老年综合评估老年慢病共病管理

老年癌症患者严重治疗相关毒性预测模型:系统综述

Prediction models for severe treatment-related toxicities in older adults with cancer: a systematic review.
PubMed 文献 · Age Ageing · 2025-01-01

模型区分度中等,临床场景和预测变量异质性显著,所有研究经PROBAST评估均为高偏倚风险。

要点

  • 最常见预测变量为身体功能(80%)、体能状态(33.3%)和MAX2指数(33.3%)。
  • 仅2个模型有外部验证,6个模型无任何验证,全部研究为高偏倚风险。

核心结论

  • 现有老年癌症患者严重治疗相关毒性预测模型区分度中等,临床场景和预测变量异质性显著。
  • 需标准化流程开发和验证预测模型,以改善这一脆弱人群严重治疗相关毒性的预测。

研究设计与样本

  • 使用PROBAST工具对纳入模型进行总结和评估。

主要发现

  • 共分析约15个预测模型,其中9个(60%)针对多种癌症类型,6个(40%)针对特定癌症类型。
  • 模型包含4至11个变量,最常见预测变量为身体功能(n=12,80%)、体能状态(n=5,33.3%)和MAX2指数(n=5,33.3%)。
  • 约2个模型(13.3%)有外部验证,9个(60.0%)有内部验证,6个(40.0%)无任何验证。
  • 所有研究经PROBAST评估均为高偏倚风险。

临床怎么用

  • 现有模型区分度中等且均为高偏倚风险,临床应用前需谨慎评估其适用性。
  • 优先关注包含身体功能、体能状态和MAX2指数等常见预测变量的模型,但需注意验证不充分的问题。

局限性

  • 所有纳入研究经PROBAST评估均为高偏倚风险。
  • 仅2个模型有外部验证,6个模型无任何验证。
  • 模型间临床场景和预测变量异质性显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ageing increases the risk of treatment-related toxicities (TRT) in patients with cancer. This systematic review provided an overview of existing prediction models for TRT in this population and evaluated their predictive performances. METHODS: A systematic search was conducted in MEDLINE (Ovid), Embase, PubMed, CINAHL and CENTRAL (Cochrane Central Register of Controlled Trials) databases for studies developing severe TRT prediction models in older cancer patients published between 1 January 2000 and 31 October 2023. The included models were summarised and assessed using the Prediction Model Risk of Bias Assessment Tool (PROBAST). RESULTS: Out of the 6192 studies identified through literature searching, 12 studies involving 90 819 participants met the inclusion criteria. About 15 prediction models (9 (60%) for diverse cancer types; 6 (40%) for specific cancer types) were analysed. The models included between 4 and 11 variables. The most common predictors were physical function (n = 12, 80%), performance status (n = 5, 33.3%) and the MAX2 index (n = 5, 33.3%). About 2 models (13.3%) had external validation, 9 (60.0%) had internal validation and 6 (40.0%) lacked any validation. All studies were assessed to have a high risk of bias according to the PROBAST criteria. CONCLUSION: This systematic review demonstrated that existing prediction models for TRT exhibited moderate discrimination ability in older patients with cancer, with significant heterogeneity in clinical settings and predictive variables. Standardised procedures for developing and validating prediction models are essential to improve the prediction of severe TRT in this vulnerable population.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Chan WL, Lau SK, Mak A, et al. Prediction models for severe treatment-related toxicities in older adults with cancer: a systematic review. Age Ageing. 2025. PMID: 40253686. doi:10.1093/ageing/afaf095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。